- Home
- XBIT
XBIT
XBiotech Inc.
as 12-20-2024 3:44pm EST
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | AUSTIN |
| Market Cap: | 211.9M | IPO Year: | 2015 |
| Target Price: | N/A | AVG Volume (30 days): | 70.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.08 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.83 - $9.96 | Next Earning Date: | 11-13-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest XBiotech Inc. News
XBIT Breaking Stock News: Dive into XBIT Ticker-Specific Updates for Smart Investing
Associated Press Finance
4 months ago
XBiotech: Q2 Earnings Snapshot
GlobeNewswire
6 months ago
XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
Associated Press Finance
7 months ago
XBiotech: Q1 Earnings Snapshot
Simply Wall St.
10 months ago
XBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 44% stake, while 44% is held by insiders
Zacks
a year ago
Strength Seen in Silence Therapeutics PLC Sponsored ADR (SLN): Can Its 15.4% Jump Turn into More Strength?
GuruFocus.com
a year ago
Chuck Royce Adjusts Position in Universal Stainless & Alloy Products Inc
GlobeNewswire
a year ago
Evolution Petroleum Schedules Fiscal Second Quarter 2024 Earnings Release and Conference Call
Zacks
a year ago
Evolution Petroleum (EPM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Compare XBIT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XBIT XBiotech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.